Dynamics of the RING domain from human TRAF6 by 15N NMR spectroscopy: Implications for biological function

Biochemistry

Volumn 47, Issue 38, 2008, Pages 10010-10017

  Markin, Craig J ^a   Saltibus, Linda F ^a   Spyracopoulos, Leo ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; TRANSCRIPTION FACTORS;

CHEMICAL EXCHANGING; POLY-UBIQUITINATION; PROTEIN-PROTEIN INTERACTIONS; UBIQUITIN LIGASE;

ENZYMES;

RING FINGER PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3;

ALPHA HELIX; ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CHEMICAL ANALYSIS; ENZYME KINETICS; ENZYME REGULATION; HUMAN; MOLECULAR DYNAMICS; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; TIME; UBIQUITINATION;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NITROGEN ISOTOPES; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RING FINGER DOMAINS; SOLUTIONS; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 52249110913     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800252x     Document Type: Article

References (61)

1. Bradley, J. R., and Pober, J. S. (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491.
2. Bodmer, J. L., Schneider, P., and Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26.
3. Liu, Y. C. (2004) Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22, 81-127.
4. Watts, T. H. (2005) TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23-68.
5. Kobayashi, T., Walsh, M. C., and Choi, Y. (2004) The role of TRAF6 in signal transduction and the immune response. Microbes Infect. 6, 1333-1338.
6. Chen, Z. J. (2005) Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765.
7. Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-κB and REL Proteins: Evolutionarily Conserved Mediators of Immune Responses. Annu. Rev. Immunol. 16, 225-260.
8. Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., Du, K., Singh, S., Pike, J. W., Darnay, B. G., Choi, Y., and Wu, H. (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447.
9. Regnier, C. H., Tomasetto, C., Moog-Lutz, C., Chenard, M. P., Wendling, C., Basset, P., and Rio, M. C. (1995) Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715-25721.
10. Mercier, P., Lewis, M. J., Hau, D. D., Saltibus, L. F., Xiao, W., and Spyracopoulos, L. (2007) Structure, interactions, and dynamics of the RING domain from human TRAF6. Protein Sci. 16, 602-614.
11. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z. J. (2000) Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361.
12. Lamothe, B., Besse, A., Campos, A. D., Webster, W. K., Wu, H., and Darnay, B. G. (2007) Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102-4112.
13. Petroski, M. D., Zhou, X., Dong, G., Daniel-Issakani, S., Payan, D. G., and Huang, J. (2007) Substrate modification with lysine 63-linked ubiquitin chains through the UBC13-UEV1A ubiquitin-conjugating enzyme. J. Biol. Chem. 282, 29936-29945.
14. He, L. S., Wu, X. L., Siegel, R., and Lipsky, P. E. (2006) TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-κB. J. Biol. Chem. 281, 11235-11249.
15. Windheim, M., Peggie, M., and Cohen, P. (2008) Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem. J. 409, 723-729.
16. Zheng, N., Wang, P., Jeffrey, P. D., and Pavletich, N. P. (2000) Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539.
17. Vander Kooi, C. W., Ohi, M. D., Rosenberg, J. A., Oldham, M. L., Newcomer, M. E., Gould, K. L., and Chazin, W. J. (2006) The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases. Biochemistry 45, 121-130.
18. Knipscheer, P., and Sixma, T. K. (2007) Protein-protein interactions regulate Ubl conjugation. Curr. Opin. Struct. Biol. 17, 665-673.
19. Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C., and Klevit, R. E. (2001) Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8, 833-837.
20. Li, Z., Cao, R., Wang, M., Myers, M. P., Zhang, Y., and Xu, R. M. (2006) Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J. Biol. Chem. 281, 20643-20649.
21. 15N NMR Relaxation. Biochemistry 33, 5984-6003.
22. 15N chemical shift anisotropy relaxation interference: Unambiguous determination of rotational diffusion tensors and chemical exchange effects in biological macromolecules. J. Am. Chem. Soc. 120, 7905-7915.
23. Tollinger, M., Skrynnikov, N. R., Mulder, F. A. A., Forman-Kay, J. D., and Kay, L. E. (2001) Slow dynamics in folded and unfolded states of an SH3 domain. J. Am. Chem. Soc. 123, 11341-11352.
24. 13C′ chemical shifts in proteins using a density functional database. J. Biomol. NMR 21, 321-333.
25. 13C′ chemical shifts in peptides using density functional theory. Biopolymers 65, 408-423.
26. Moon, S., and Case, D. A. (2007) A new model for chemical shifts of amide hydrogens in proteins. J. Biomol NMR 38, 139-150.
27. Smillie, L., and Nattriss, M. (1991) in High-performance liquid chromatography of peptides and proteins: Separation, analysis, and conformation (Mant, C. T., and Hodges, R. S., Eds.) pp 847-848, CRC Press, Boca Raton, FL.
28. 147-163 induces a structural opening in human cardiac troponin-C. Biochemistry 38, 8289-8298.
29. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX Pipes. J. Biomol. NMR 6, 277-293.
30. Goddard, T. D., and Kneller, D. G. (2006) Sparky, University of California, San Francisco.
31. Loria, J. P., Ranee, M., and Palmer, A. G. (1999) A relaxation- compensated Carr-Purcell-Meiboom-Gill sequence for characterizing chemical exchange by NMR spectroscopy. J. Am. Chem. Soc. 121, 2331-2332.
32. 15N relaxation dispersion NMR spectroscopy: Application to Asn and Gln residues in a cavity mutant of T4 lysozyme. J. Am. Chem. Soc. 123, 967-975.
33. Kovrigin, E. L., Kempf, J. G., Grey, M. J., and Loria, J. P. (2006) Faithful estimation of dynamics parameters from CPMG relaxation dispersion measurements. J. Magn. Reson. 180, 93-104.
34. Palmer, A. G., Kroenke, C. D., and Loria, J. P. (2001) Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Enzymol. 339, 204-238.
35. Mandel, A. M., Akke, M., and Palmer, A. G. (1995) Backbone dynamics of Escherichia coli ribonuclease HI: Correlations with structure and function in an active enzyme. J. Mol. Biol. 246, 144-163.
36. 15N NMR relaxation data. J. Biomol. NMR 36, 215-224.
37. d'Auvergne, E. J., and Gooley, P. R. (2003) The use of model selection in the model-free analysis of protein dynamics. J. Biomol. NMR 25, 25-39.
38. Horn, R. (1987) Statistical methods for model discrimination: Applications to gating kinetics and permeation of the acetylcholine-receptor channel. Biophys. J. 51, 255-263.
39. 2 upon Carr-Purcell pulse separation. J. Magn. Reson. 6, 89-105.
40. Markley, J. L., Bax, A., Arata, Y., Hilbers, C. W., Kaptein, R., Sykes, B. D., Wright, P. E., and Wüthrich, K. (1998) Recommendations for the presentation of NMR structures of proteins and nucleic acids (IUPAC Recommendations 1998). Pure Appl. Chem. 70, 117-142.
41. Murphy, J. M., Korzhnev, D. M., Ceccarelli, D. F., Briant, D. J., Zarrine-Afsar, A., Sicheri, F., Kay, L. E., and Pawson, T. (2007) Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain. Proc. Natl. Acad. Sci. U.S.A. 104, 14336-14341.
42. Das, R., Abu-Abed, M., and Melacini, G. (2006) Mapping allostery through equilibrium perturbation NMR spectroscopy. J. Am. Chem. Soc. 128, 8406-8407.
43. Sugase, K., Dyson, H. J., and Wright, P. E. (2007) Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447, 1021-1025.
44. 13C NMR spin relaxation. J. Am. Chem. Soc. 122, 11610-11619.
45. 15N CPMG relaxation dispersion NMR: The GB1(A34F) monomer-dimer equilibrium. J. Phys. Chem. B 112, 6008-6012.
46. Spyracopoulos, L., Lavigne, P., Crump, M. P., Gagné, S. M., Kay, C. M., and Sykes, B. D. (2001) Temperature dependence of dynamics and thermodynamics of the regulatory domain of human cardiac troponin C. Biochemistry 40, 12541-12551.
47. Hass, M. A. S., Hansen, D. F., Christensen, H. E. M., Led, J. J., and Kay, L. E. (2008) Characterization of conformational exchange of a histidine side chain: Protonation, rotamerization, and tau-tomerization of His61 in plastocyanin from Anabaena variabilis. J. Am. Chem. Soc. 130, 8460-8470.
48. Roehm, P. C., and Berg, J. M. (1997) Sequential metal binding by the RING finger domain of BRCA1. Biochemistry 36, 10240-10245.
49. Houben, K., Wasielewski, E., Dominguez, C, Kellenberger, E., Atkinson, R. A., Timmers, H. T., Kieffer, B., and Boelens, R. (2005) Dynamics and metal exchange properties of C4C4 RING domains from CNOT4 and the p44 subunit of TFIIH. J. Mol. Biol. 349, 621-637.
50. Kabsch, W., and Sander, C. (1983) Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637.
51. Millet, O., Loria, J. P., Kroenke, C. D., Pons, M., and Palmer, A. G. (2000) The static magnetic field dependence of chemical exchange linebroadening defines the NMR chemical shift time scale. J. Am. Chem. Soc. 122, 2867-2877.
52. 15N NMR relaxation. J. Am. Chem. Soc. 117, 12562-12566.
53. Kentsis, A., Gordon, R. E., and Borden, K. L. B. (2002) Control of biochemical reactions through supramolecular RING domain self-assembly. Proc. Natl. Acad. Sci. U.S.A. 99, 15404-15409.
54. Pullen, S. S., Labadia, M. E., Ingraham, R. H., McWhirter, S. M., Everdeen, D. S., Alber, T., Crute, J. J., and Kehry, M. R. (1999) High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38, 10168-10177.
55. Wu, H., and Arron, J. R. (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. BioEssays 25, 1096-1105.
56. Heldin, C. H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
57. Xu, Z., Devlin, K. I., Ford, M. G., Nix, J. C., Qin, J., and Misra, S. (2006) Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. Biochemistry 45, 4749-4759.
58. Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., and Wright, P. E. (2006) Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J. Mol. Biol. 363, 433-450.
59. Bellon, S. F., Rodgers, K. K., Schatz, D. G., Coleman, J. E., and Steitz, T. A. (1997) Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster. Nat. Struct. Biol. 4, 586-591.
60. Baron, R., and McCammon, J. A. (2008) (Thermo)dynamic role of receptor flexibility, entropy, and motional correlation in protein-ligand binding. ChemPhysChem 9, 983-988.
61. Perazzolo, C., Verde, M., Homans, S. W., and Bodenhausen, G. (2007) Evidence of chemical exchange in recombinant Major Urinary Protein and quenching thereof upon pheromone binding. J. Biomol. NMR 38, 3-9.